- Prospective trial at Duke Medical Center evaluating a remote patient monitoring platform
- Using a PSSUQ survey, patients noted that the TempTraq was easier to use than a thermometer.
- “The mean overall compliance was 93.1% for TempTraq and 85.5% for VitalTraq. Specifically, when at home, the mean compliance was significantly higher for TempTraq than SOC thermometers (92.9% vs. 69.6%, p < 0.001).”
- “Remote monitoring detected CRS 28.2 hours faster and had greater home compliance compared to SOC, potentially enabling earlier intervention and allowing institutions to ease patient proximity requirements to the treating center.”
Remote multi-vital sign monitoring allows earlier detection of cytokine release syndrome after bispecific T cell engager and chimeric antigen receptor T cell therapies
Duke